Drug-eluting stents: more dollars than sense?

JACC Cardiovasc Interv. 2009 Dec;2(12):1188-9. doi: 10.1016/j.jcin.2009.11.001.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary / adverse effects
  • Angioplasty, Balloon, Coronary / economics*
  • Angioplasty, Balloon, Coronary / instrumentation
  • Angioplasty, Balloon, Coronary / mortality
  • Coronary Artery Disease / economics*
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / therapy
  • Cost Savings
  • Cost-Benefit Analysis
  • Drug Costs
  • Drug Therapy, Combination
  • Drug-Eluting Stents / economics*
  • Health Care Costs*
  • Humans
  • Metals*
  • Myocardial Infarction / economics
  • Myocardial Infarction / etiology
  • Platelet Aggregation Inhibitors / economics
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prosthesis Design
  • Stents / economics*
  • Time Factors
  • Treatment Outcome

Substances

  • Metals
  • Platelet Aggregation Inhibitors